Researchers sought to determine whether CAR-T therapy would be safe and effective in patients with CLL and Richter transformation.

Fedratinib can reduce symptoms and spleen volume in patients with myelodysplastic syndrome (MDS) or myeloproliferative neoplasms (MPNs), according to research presented at the ASH ...

Researchers conducted a 10-year nationwide retrospective matched cohort study to compare the risk for cancer in people with multiple sclerosis and a matched sample.

Enfortumab vedotin may be a treatment option for patients with advanced head and neck cancer that is not amenable to definitive local therapy, researchers say. They reported phase 2 results with ...

Breast cancer prevention efforts should include population-wide policies and regulations to reduce air pollution, according to researchers.

Lower cumulative incidence reported for two-year physician-scored toxicity and late-grade ≥2 toxicity with MRI guidance.

Researchers sought to determine whether it would be beneficial to add inotuzumab to the CALGB 10403 pediatric regimen in the treatment of young adults with CD22-positive B-ALL.

Teclistamab maintenance, given alone or in combination with lenalidomide, appeared to be safe and demonstrated “unprecedented efficacy” in patients with multiple myeloma in the phase 3 MajesTEC-4 ...

Revumenib, venetoclax, and ASTX727 (a fixed-dose combination of decitabine and cedazuridine) demonstrated efficacy in patients with relapsed or refractory AML.

IFRT only needs to be considered for PET-negative patients at high risk of recurrence, according to John Radford, MD.

Adding blinatumomab to chemotherapy improved disease-free survival in children with NCI standard-risk B-cell ALL.

A prospective, longitudinal study sought to determine the effects of nutrition status, daily habits, and sleep pattern on length of stay in patients with ovarian cancer undergoing chemotherapy.